Brief: Surmodics Announces 12-Month Data From The Swing Trial Presented At VEITHsymposium
17/11/2022 13:42
Nov 17 (Reuters) - Surmodics Inc SRDX.O :
* SURMODICS ANNOUNCES 12-MONTH DATA FROM THE SWING TRIAL
PRESENTED
AT VEITHSYMPOSIUM
* SURMODICS INC - SUNDANCE SIROLIMUS DRUG-COATED BALLOON
EXHIBITS
EXCELLENT SAFETY PROFILE
* SURMODICS INC - PRIMARY PATENCY MAINTAINED AT 12 MONTHS IN
80%
OF PER PROTOCOL ANALYSIS POPULATION
Source text for Eikon: ID:nBw4WQ0PSa
Further company coverage: SRDX.O
Recent news on SurModics
See all newsU.S. STOCKS ON THE MOVE-Surmodics, Cheniere Energy, American Public Education
U.S. STOCKS ON THE MOVE-Surmodics, Energy stocks, American Public Education
Surmodics jumps after US judge rejects FTC's bid to block acquisition by GTCR
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions